ClinicalTrials.govpublic full text
Neoadjuvant Nivolumab Plus Ipilimumab in Resectable NSCLC (GALAXY 3)
lung cancer - non small cell
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 414502
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.